期刊文献+

百令胶囊对慢性阻塞性肺病患者血清细胞因子与肺功能的影响 被引量:9

The effects of bailing capsule on levels of cytokines in serum and lung functions in patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的:探讨百令胶囊对稳定期慢性阻塞性肺病(chronic obstructive pulmonary disease,COPD)患者血清TNF-α、IL-8、GM-CSF水平及FVC、FEV1、FEV1/FVC的影响。方法:对照组、患病组行肺功能中FVC、FEV1检测(包括支气管扩张试验)。采用ELISA方法测定各组血清中TNF-α、IL-8、GM-CSF水平。用纤维支气管镜取患病组肺组织,在光镜下观察。治疗组口服百令胶囊30d后用同样的方法测定上述指标。结果:患病组血清TNF-α、IL-8、GM-CSF的水平较对照组高,患病Ⅰ组、Ⅱ组、Ⅲ组随分级的增加而增高(P<0.05)。Ⅲ组患者细胞因子水平最高,分别是(28.46±9.47)pg/mL、(100.37±4.90)pg/mL、(146.00±18.85)pg/mL。治疗后TNF-α、IL-8、GM-CSF在血清水平明显下降(P<0.05),而FVC、FEV1及FVE1/FVC在治疗后有明显的升高(P<0.05)。光镜下观察治疗前后肺组织纤维增生无明显改变。结论:慢性阻塞性肺病患者血清中的细胞因子水平高于健康对照组,在不同级别存在差异(P<0.05),分级越高因子水平越高。百令胶囊可降低COPD血清中增高的细胞因子水平,进而改善COPD患者的肺功能。 Objective: To investigate the effects of Bailing capsule on serum levels of TNF-α, IL-8, GM-CSF and pulmonary functions in patients with chronic obstructive pulmonary disease (COPD). Methods: The determinations of FEV1,FVC including bronchodilation test were performed for both control and illness groups. The levels of TNF-α,IL-8,GM-CSF in serum were tested by ELISA. Pulmonary tissues were taken by fiberbronchialtroscope and observed by Optic Microscope. The same parameters were checked after taking bailing capsule for 30 days. Results: The level of TNF-α, GM- CSF,IL-8 level in patients were higher than in control, and these cell factors level were gradually high with the grade(P〈0.05), TNF-α,GM-CSF,IL-8 level in Ⅲ group were higher than in two other groups, respectively (28.46±9.47) pg/mL, (100.37±4.90) pg/mL, (146±18.85) pg/mL. The amount of FVC, FEV1 in every group were significantly improved with the cell factors level decreased in serum after being treated by taking bailingjiaonang (P〈0.05). The lung tissues were not changed under optical microscope after being treated. Conclusions: The cell factors level in COPD patients were higher than in control, and there were different for the cell factors level in COPD every group (P〈0.05), The level of cell factors in Ⅲ group were highest, Ⅱ group were second, Ⅰ group were final. Bailingjiaonang may decrease the level of TNF-α,GM-CSF,IL-8 in serum, as well as improve significantly the lung function of COPD.
出处 《海南医学院学报》 CAS 2006年第1期34-37,共4页 Journal of Hainan Medical University
关键词 肺疾病 阻塞性 呼吸功能试验 肿瘤坏死因子-α 白介素-8 粒-巨细胞集落刺激因子 COPD Determinations of lung function TNF-α IL-8 GM-CSF
  • 相关文献

参考文献11

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2张惠兰,张珍祥,徐永键.慢性阻塞性肺疾病的十年回顾[J].中国呼吸与危重监护杂志,2002,1(3):134-137. 被引量:26
  • 3William MacNee. Oxidants/Antioxidants and COPD[J].Chest,2000,117(5) :303-317.
  • 4Mehmet kaycan, Michiel Vankrugten, Herman-Jan Pennings, et al. Tumor Necrosis Factor-α+489G/A gene polymorphism is associated with chronic obstructive pulmonary disease[J]. Respiratory Research, 2002,3 (1):1-7.
  • 5L G Wood, P G Gibson, M L Garg. Biomarkers of lipid peroxidation, airway inflammation and asthma [J]. Eur Respir J,2003,21 (1):177-186.
  • 6Beeh KM, Kommann O, Buhl R, et al. Giembycz MA and Barnes PJ: Neutrophil Chemotactic Activity of SputumFromPatients With COPD: Role of Interleukin 8 and Leukotfiene B[J]. Chest,2003,123(4):1240-1247.
  • 7Churg A, Dai J, Tai H, et al. Tumor necrosis factor-alpha was central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am. J. Respir[J].Cfit. Cwere Med, 2002,166(6) : 849-854.
  • 8张念志,赵丽萍,卓秀珍,季红燕,李泽庚,王胜,韩明向.参七虫草胶囊对慢性阻塞性肺疾病大鼠模型肿瘤坏死因子-αmRNA表达的影响[J].中国中医急症,2004,13(2):107-108. 被引量:19
  • 9Peter J Barnes. Cytokine-directed therapies for the treatment of chronic airway diseases[J]. P.J. Barnes/Cytokine & Growth Factor Reviews,2003,14 (6):511-522.
  • 10De Godoy I, Donahoe M, Calhoun WJ, et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients[J]. Am J Respir Crit Cwere Med, 1996,153(2): 633-637.

二级参考文献43

  • 1张波,刘树芬,马晓星,齐法莲,孙文杰.慢性阻塞性肺病患者细胞粘附分子表达研究[J].免疫学杂志,1996,12(4):243-246. 被引量:3
  • 2王申五 白桃.细胞总RNA的制备.基因操作技术[M].北京:北京医科大学中国协和医科大学联合出版社,1991.46-48.
  • 3Feinleib M,Rosenberg HM,Collins JG,et al.Trends in COPD morbidity and mortality in the United States.Am Rev Respir Dis,1989;140:s9~s18
  • 4Soriano JB,Maier WC,Egger P, et al.Recent trends in physician diagonosed COPD in women and men in the UK.Thorax,2000; 55:789~794
  • 5Stang P,Lydick E,Silberman C,et al.The prevalence of COPD:using smoking rates to estimate disease frequency in the general population.Chest,2000;117:354s~359s
  • 6Fletcher C,Peto R.The natural history of chronic airflow obstruction.Br Med J,1997;1:1645~1648
  • 7程显声,李景图,张珍祥,等.慢性阻塞性肺疾病、肺心病人群防治的研究基线资料分析.见:程显声,主编.慢性阻塞性肺疾病论文集.北京:北京军事谊文出版社,2001;1-21
  • 8Silverman EK.Genetics of chronic obstructive pulmonary disease.Novartis Found Symp,2001; 234:45~58
  • 9Emi M,Keicho N,Tokunaga K, et al.Association of diffuse panbronchiolitis with microsatellite polylmorphism of the human interleukin-8(IL-8)gene.J Hum Genet,1999;44:169~172
  • 10Sandford AJ,Pare PD.Genetic risk factors for chronic obstructive pulmonary disease.Clin Chest Med,2000;21:633~643

共引文献5141

同被引文献169

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部